Profile: CSL Behring deals with research, development, manufacturing and marketing biotherapies that are used to treat serious & rare conditions such as coagulation disorders such as hemophilia & von Willebrand disease, immune deficiencies and genetic emphysema. Our Cytogam® is indicated for the prophylaxis of cytomegalovirus disease associated with transplantation of kidney, lung, liver, pancreas, and heart. Our Helixate® FS is indicated for the treatment of classical hemophilia in which there is a demonstrated deficiency of activity of the plasma clotting factor VIII.
The company has revenues of > USD 1 Billion, has ~8400 employees and is CE certified.
FDA Registration Number: 1410248
5 Products/Services (Click for related suppliers)
|
• Intravascular Infusion Controller (FDA Code: LDR / 880.5725) |
• Intravenous Administration Kit (FDA Code: FPA / 880.5440) An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container. |
• Pharmaceuticals |
• Pharmaceuticals Bags |
• Thyroid Autoantibody Test System (FDA Code: JZO / 866.5870) A thyroid autoantibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the thyroid autoantibodies (antibodies produced against the body's own tissues). Measurement of thyroid autoantibodies may aid in the diagnosis of certain thyroid disorders, such as Hashimoto's disease (chronic lymphocytic thyroiditis), nontoxic goiter (enlargement of thyroid gland), Grave's disease (enlargement of the thyroid gland with protrusion of the eyeballs), and cancer of the thyroid. |